- Market Realist•yesterday
Pfizer-Medivation deal On September 27, 2016, Pfizer (PFE) completed the acquisition of Medivation (MDVN). The stock transaction is valued at $81.50 per Medivation share, resulting in a total enterprise ...
- Business Wire•3 days ago
Pfizer Inc. today announced the successful completion of its acquisition of Medivation, Inc. . As of the tender offer expiration, 115,574,041 shares of Medivation common stock were validly tendered, representing approximately 69.1% of the shares outstanding and have been accepted for payment under the terms of the tender offer for $81.50 per share in cash, without interest, subject to any required ...
- Marketwired•3 days ago
Medivation, Inc. today announced that new data from Company-sponsored and investigator-initiated clinical trials will be presented at the European Society for Medical Oncology 2016 Congress, being held ...
Medivation, Inc. (MDVN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Day's Range||81.43 - 81.48|
|52wk Range||26.41 - 81.48|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-75.34|
|Avg Vol (3m)||4,284,740|
|Dividend & Yield||N/A (N/A)|